KAI Research: KAI secures CDC contract to support annual influenza vaccine serology testing

KAI Research (KAI), a wholly owned subsidiary of Altarum Institute, announced today that the Centers for Disease Control and Prevention (CDC) awarded it a contract to evaluate samples of pediatric, adult, and elderly individuals' serum levels after flu vaccination to determine whether antibodies induced by the current vaccine effectively inhibit circulating influenza viruses.